Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              Increasing Ecopipam Exposure Improves Yale Global Tic Severity Scale-Total Tic Scores (YGTSS-TTS) in Children and Adolescents with Tourette Syndrome (TS): Results from a Population Pharmacokinetic (popPK) Model-Based Simulation Using D1AMOND Trial Data

              Author:Freidy, Soha   Dumitrescu, Teodora   Schmith, Virginia   Gilbert, Donald   Mahableshwarkar, Atul   Dubow, Jordan   Cunniff, Timothy   Kim, David   Miller, Meredith   Wanaski, Stephen   

              Session Name:P5: Child Neurology and Developmental Neurology: Movement Disorders  

              Topic:Child Neurology and Developmental Neurology  

              Program Number:P5.007  

              Author Institution:Allucent, Research Triangle Park, NC  Schmith PK/PD Consulting, LLC, Cocoa Beach, FL  Cincinnati Children's Hospital Med. Ctr., OH - Ohio, OH  Emalex Biosciences, Chicago, IL  Paragon Biosciences, Chicago, IL  

              Design of a Phase 3 Maintenance-of-Effect Trial of Ecopipam in Tourette Syndrome

              Author:Cunniff, Timothy   Gilbert, Donald   Wanaski, Stephen   Bittman, Richard   Dubow, Jordan   Mahableshwarkar, Atul   

              Session Name:P12: Movement Disorders: Tic Disorders and Drug-Induced Movement Disorders 2  

              Topic:Movement Disorders  

              Program Number:P12.011  

              Author Institution:Paragon Biosciences, LLC, Northbrook, IL  Cincinnati Children's Hospital Medical Center, OH - Ohio, OH  Paragon Biosciences, LLC, Chicago, IL  Bittman Biostat, Inc., Naples, FL  Paragon Biosciences, LLC, Sarasota, FL  Emalex Biosciences, Inc., Chicago, IL